Advancements in healthcare technology are reshaping chronic disease management, with recent research highlighting significant cost benefits through remote patient monitoring practices for hypertension.
A study published in JMIR Cardio on May 8, 2025, evaluates the cost-effectiveness of Home Blood Pressure Telemonitoring (HBPT) compared to traditional hypertension management. Utilizing a decision-analytic Markov model over a 30-year period, the research assesses health outcomes and associated costs from a societal perspective.
Study Overview
The researchers modeled a hypothetical cohort of 1,000 patients with an average age of 65.3 years, comparing HBPT interventions with standard care (SOC). The HBPT program, implemented by Maasstad Hospital in Rotterdam, involved fewer in-person outpatient department consultations. The study incorporated various health states, including different blood pressure levels and cardiovascular events, to predict long-term outcomes.
Key Findings
Initial analysis indicated that HBPT was not cost-effective under standard parameters, with an incremental cost-effectiveness ratio (ICER) of €20,386 per quality-adjusted life year (QALY). However, sensitivity analyses revealed that reducing the number of in-person visits significantly improved HBPT’s cost-effectiveness. For instance, decreasing annual in-person consultations to 1.48 brought the ICER below the willingness-to-pay threshold, and further reduction to 1.18 made HBPT cost-saving. Additionally, extending the clinical effectiveness of HBPT and targeting younger patients enhanced its economic viability.
- Minor reductions in clinic visits can make HBPT economically favorable.
- Longer-lasting clinical benefits of HBPT improve cost-effectiveness.
- Targeting patients under 65 years old further enhances HBPT’s value.
Implementing HBPT could offer a practical solution to managing hypertension more efficiently by leveraging remote monitoring technologies. This approach not only reduces healthcare costs but also streamlines patient care, potentially leading to broader adoption in clinical settings.
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
